Assembleable artificial bone plate and artificial bone plate unit

An artificial bone plate unit comprising:

• a plate body formed unitarily and having
• two main surfaces;
• a peripheral surface connected between the two main surfaces;
• multiple connecting pins formed on the plate body and arranged along the peripheral surface on the plate body;
• multiple drug cavities formed in the artificial bone plate unit;
• and
• multiple drug-releasing openings formed on the artificial bone plate unit;
• each of the drug-releasing openings connected to a respective one of the drug cavities;
• multiple drug-releasing channels;
• each of the drug-releasing channels connecting a respective one of the drug-releasing openings and a respective one of the drug cavities, such that a drug disposed within each of the multiple drug cavities is released directly through the respective one of the drug-releasing channels and the respective one of the drug-releasing openings;
• and
• wherein a maximum area of a cross section of each of the drug cavities is greater than an area of a cross section of the respective one of the drug-releasing channels.

An artificial bone plate unit comprising:

• a plate body formed unitarily and having
• two main surfaces;
• a peripheral surface connected between the two main surfaces;
• multiple connecting pins formed on the plate body and arranged along the peripheral surface on the plate body;
• multiple connecting holes formed in the plate body and arranged along the peripheral surface in the plate body;
• and
• multiple drug cavities formed in the artificial bone plate unit;
• multiple drug-releasing openings formed on the artificial bone plate unit;
• each of the drug-releasing openings connected to a respective one of the drug cavities;
• multiple drug-releasing channels;
• each of the drug-releasing channels connecting a respective one of the drug-releasing openings and a respective one of the drug cavities, such that a drug disposed within each of the multiple drug cavities is released directly through the respective one of the drug-releasing channels and the respective one of the drug-releasing openings;
• and
• wherein a maximum area of a cross section of each of the drug cavities is greater than an area of a cross section of the respective one of the drug-releasing channels.